The management of the myelodysplastic child: a paradigm shift
2003; Wiley; Volume: 92; Issue: s1 Linguagem: Inglês
10.1046/j.1464-410x.92.s1.2.x
ISSN1464-410X
Autores Tópico(s)Pediatric Urology and Nephrology Studies
ResumoBJU InternationalVolume 92, Issue s1 p. 23-28 The management of the myelodysplastic child: a paradigm shift S.B. Bauer, Corresponding Author S.B. Bauer Department of Urology, Children's Hospital, Harvard Medical School, Boston, MA, USAS.B. Bauer, Department of Urology, Children's Hospital, 300 Longwood Avenue, 02115 Boston, MA, USA. e-mail: [email protected]Search for more papers by this author S.B. Bauer, Corresponding Author S.B. Bauer Department of Urology, Children's Hospital, Harvard Medical School, Boston, MA, USAS.B. Bauer, Department of Urology, Children's Hospital, 300 Longwood Avenue, 02115 Boston, MA, USA. e-mail: [email protected]Search for more papers by this author First published: 12 September 2003 https://doi.org/10.1046/j.1464-410X.92.s1.2.xCitations: 35Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat REFERENCES 1 Smith ED. Urinary prognosis in spina bifida. J Urol 1972; 108: 115 2 Retik AB, Perlmutter AD, Gross RE. Cutaneous uretero-ileostomy in children. N Eng J Med 1967; 277: 217–22 3 Lapides J, Diokno AC, Silber SJ, Lowe BS. Clean intermittent self-catheterization in the treatment of urinary tract disease. J Urol 1972; 107: 458 4 Guttmann L, Frankel H. The value of intermittent catheterization in the early management of traumatic paraplegia and tetraplegia. Paraplegia 1966; 4: 63 5 Jeffs RD, Jones P, Schillinger JF. Surgical correction of vesico-ureteral reflux in children with neurogenic bladder. J Urol 1976; 115: 449 6 Gierup J, Ericsson NO, Okmain L. Micturition studies in infants and children. Scand J Urol Nephrol 1979; 3: 1 7 Bates CP, Whiteside CG, Turner-Warwick RT. Synchronous cine/pressure/flow/cysto-urethrography with special reference to stress and urge incontinence. Br J Urol 1970; 42: 714 8 Diokno AC, Koff SA, Bender LF. Periurethral striated muscle activity in neurogenic bladder dysfunction. J Urol 1974; 112: 743 9 Blaivas JG, Labib KB, Bauer SB, Retik AB. Changing concepts in the urodynamic evaluation of children. J Urol 1977; 117: 777–81 10 Scott FB, Bradley WE, Timm GW, Kothari D. Treatment of incontinence secondary to myelodysplasia by an implantable prosthetic urinary sphincter. South Med J 1973; 66: 987 11 Gonzalez R, DeWolf WC. The artificial bladder sphincter AS-721 for the treatment of incontinence in patients with neurogenic bladder. J Urol 1979; 121: 71 12 Barrett DM, Furlow WL. The management of severe urinary incontinence in patients with myelodysplasia by implantation of the AS 791/792 urinary sphincter device. J Urol 1982; 128: 44 13 Shapiro SR, Lebowitz RL, Colodny AH. Fate of 90 children with ileal conduit urinary diversion a decade later; analysis of complications, pyeloplasty, renal function and bacteriology. J Urol 1975; 114: 289 14 Schwarz GR, Jeffs RD. Ileal conduit diversion in children. computer analysis of follow-up from 2 to 16 years. J Urol 1975; 114: 285 15 Hendren WH. Urinary diversion and undiversion in children. Surg Clin North Am 1976; 56: 425 16 Geraniotis E, Koff SA, Enrile B. Prophylactic use of clean intermittent catheterization in treatment of infants and young children with myelomeningocele and neurogenic bladder dysfunction. J Urol 1988; 139: 85 17 Kasabian NG, Bauer SB, Dyro FM, Colodny AH, Mandell J, Retik AB. The prophylactic value of clean intermittent catheterization and anticholinergic medication in newborns and infants with myelodysplasia at risk of developing urinary tract deterioration. Am J Dis Child 1992; 146: 840 18 Perez LM, Khoury J, Webster GD. The value of urodynamic studies in infants less than one year old with congenital spinal dysraphism. J Urol 1992; 148: 584 19 McGuire EJ, Woodside JR, Borden TA, Weiss RM. The prognostic value of urodynamic testing in myelodysplastic patients. J Urol 1981; 126: 205 20 Bauer SB, Hallet M, Khoshbin S et al. The predictive value of urodynamic evaluation in the newborn with myelodysplasia. JAMA 1984; 152: 650–3 21 Sidi AA, Dykstra DD, Gonzalez R. The value of urodynamic testing in the management of neonates with myelodysplasia: a prospective study. J Urol 1986; 135: 90 22 Bauer SB. The management of spina bifida from birth onwards. In RH Whitaker, JR Woodard eds, Paediatric Urology. London: Butterworths, 1985: 87–112 23 Joseph DB, Bauer SB, Colodny AH, Mandell J, Retik AB. Clean intermittent catheterization in infants with neurogenic bladder. Pediatrics 1989; 84: 78 24 Kaufman AM, Ritchey ML, Roberts AC et al. Decreased bladder compliance in patients with myelomeningocele treated with radiologic observation. J Urol 1996; 156: 2031–3 25 Edelstein RA, Bauer SB, Kelly MD et al. Long-term urologic response of neonates with myelodysplasia treated proactively with intermittent catheterization and anticholinergic therapy. J Urol 1995; 150: 1500 26 Wu HY, Baskin LS, Kogan BA. Neurogenic bladder dysfunction due to myelomeningocele: neonatal versus childhood treatment. J Urol 1997; 157: 2295–7 27 Tanaka H, Kakizaki H, Kobayashi S et al. The relevance of urethral resistance in children with myelodysplasia: its impact on upper urinary tract deterioration and the outcome of conservative management. J Urol 1999; 161: 929–32 28 Klose AG, Sackett CK, Mesrobian H-GJ. Management of children with myelodysplasia: urological alternatives. J Urol 1990; 144: 1446–9 29 Teichman JMH, Scherz HC, Kim KD et al. An alternative approach to myelodysplasia management. aggressive observation and prompt intervention. J Urol 1994; 152: 807 30 Kaplan WE, Firlit CF. Management of reflux in myelodysplastic children. J Urol 1983; 129: 1195 31 Bauer SB, Colodny AH, Retik AB. The management of vesico-ureteral reflux in children with myelodysplasia. J Urol 1982; 128: 102 32 Kass EJ, Koff SA, Lapides J. Fate of vesico-ureteral reflux in children with neuropathic bladders managed by intermittent catheterization. J Urol 1981; 125: 63 33 Bauer SB. Vesico-ureteral reflux in children with neurogenic bladder dysfunction. In JH Johnston ed. International Perspectives in Urology, Vol. 10. Baltimore: Williams & Wilkins, 1984: 159–77 34 Landau EH, Churchill BM, Jayanthi VR et al. The sensitivity of pressure specific bladder volume versus total bladder capacity as a measure of bladder storage dysfunction. J Urol 1994; 152: 1578 35 Duckett JW. Cutaneous vesicostomy in childhood. Urol Clin North Am 1974; 1: 485 36 Mandell J, Bauer SB, Colodny AH, Retik AB. Cutaneous vesicostomy in infancy. J Urol 1981; 126: 92 37 Bloom DA, Knechtel JM, McGuire EJ. Urethral dilation improves bladder compliance in children with myelomeningocele and high leak point pressures. J Urol 1990; 144: 430 38 Barbalias GA, Klauber GT, Blaivas JG. Critical evaluation of the Credé maneuver: a urodynamic study of 207 patients. J Urol 1983; 130: 720 39 Mulcahy JJ, James HE, McRoberts JW. Oxybutynin chloride combined with intermittent clean catheterization in the treatment of myelomeningocele patients. J Urol 1977; 118: 95–6 40 Purcell MH, Gregory JG. Intermittent catheterization. evaluation of complete dryness and independence in children with myelomeningocele. J Urol 1984; 132: 518–20 41 Hehir M, Fitzpatrick JM. Oxybutinin and the prevention of urinary incontinence in spina bifida. Eur Urol 1985; 11: 254–6 42 Goessl C, Sauter T, Michael T et al. Efficacy and tolerability of tolterodine in children with hyperreflexia. Urology 2000; 55: 414–8 43 Castro-Gago M, Novo I, Cimadevila A, Pena J, Rodriguez-Nunez A, Marques-Queimadelos A. Management of neurogenic bladder dysfunction secondary to myelomeningocele. Eur J Pediatr 1990; 150: 62–5 44 Mitchell ME, Pizer JA. Intestinocystoplasty and total bladder replacement in children and young adults: follow-up of 129 cases. J Urol 1987; 138: 1140 45 Sidi AA, Aliabadi H, Gonzalez R. Enterocystoplasty in the management and reconstruction of the pediatric neurogenic bladder. J Pediatr Surg 1987; 22: 153 46 Hernandez RD, Hurwitz RS, Foote JE et al. Nonsurgical management of threatened upper urinary tracts and incontinence in children with myelomeningocele. J Urol 1994; 152: 1582 47 Adams MC, Mitchell ME, Rink RC. Gastrocystoplasty. an alternative solution to the problem of urological reconstruction in the severely compromised patient. J Urol 1988; 140: 1152 48 Gosalbez R Jr, Woodard JR, Broecker BH, Warshaw B. Metabolic complications of the use of stomach for urinary reconstruction. J Urol 1993; 150: 710 49 Khoury AE, Salomon M, Doche R, Soboh F et al. Stone formation after augmentation cystoplasty. the role of intestinal mucus. J Urol 1997; 158: 1133–7 50 Kurzrock EA, Baskin LA, Kogan BA. Gastrocystoplasty: long-term results. J Urol 1998; 160: 2182–6 51 Goldwasser B, Barrett DM, Webster GD, Kramer SA. Cystometric properties of ileum and right colon after bladder augmentation, substitution and replacement. J Urol 1987; 138: 1007 52 Hinman F Jr. Selection of intestinal segments for bladder substitution: physical and physiological characteristics. J Urol 1988; 139: 519 53 Gonzalez R, Reid C, Reinberg Y, Buson H. Seromuscular enterocystoplasty lined with urothelium (SEIU): experience with 12 patients. J Urol 1994; 151: 235 54 Nguyen DH, Mitchell ME, Horowitz M et al. Demucosalized augmentation gastrocystoplasty with bladder autoaugmentation in pediatric patients. J Urol 1996; 156: 206–9 55 Carr MC, Docimo SG, Mitchell ME. Bladder augmentation with urothelial preservation. J Urol 1999; 162: 1133– 7 56 Oberpenning F, Meng J, Yoo JJ, Atala A. De novo reconstitution of a functional mammalian urinary bladder by tissue engineering. Nat Biotechnol 1999; 17: 149–55 57 Kaefer M, Pabby A, Kelly M, Darbey M, Bauer SB. Improved bladder function after prophylactic treatment of high risk neurogenic bladder in newborns with myelodysplasia. J Urol 1999; 162: 1068 58 Light JK, Hawila M, Scott FB. Treatment of urinary incontinence in children: the artificial sphincter versus other methods. J Urol 1983; 130: 518 59 Bosco PJ, Bauer SB, Colodny AH et al. The long-term follow-up of artificial urinary sphincters in children. J Urol 1991; 146: 396 60 Levesque PE, Bauer SB, Atala A et al. Ten-year experience with artificial urinary sphincter in children. J Urol 1996; 156: 625 61 Kryger JV, Spencer Barthold J, Fleming P. The outcome of artificial urinary sphincter placement after a mean of 15 years' follow-up in a paediatric population. BJU Int 1999; 83: 1026–31 62 Roth DR, Vyas PR, Kroovand RL, Perlmutter AD. Urinary tract deterioration associated with the artificial urinary sphincter. J Urol 1986; 135: 528–30 63 Bauer SB, Reda EF, Colodny AH, Retik AB. Detrusor instability: a delayed complication in association with the artificial sphincter. J Urol 1986; 135: 1212–5 64 Kropp KA, Angwafo FF. Urethral lengthening and reimplantation for neurogenic incontinence in children. J Urol 1986; 135: 533 65 Nil TG, Peller PA, Kropp KA. Management of urinary incontinence by bladder tube urethral lengthening and submucosal reimplantation. J Urol 1990; 144: 559–61 66 Belman AB, Kaplan GW. Experience with the Kropp anti-incontinence procedure. J Urol 1989; 141: 1160–2 67 Pippi Salle JL, De Fraga JCS, Amarante A et al. Urethral lengthening with anterior bladder wall flap for urinary incontinence: a new approach. J Urol 1994; 152: 802–6 68 Hayes MC, Bulusu T, Terry T, Mouriquand PDE, Malone PS. The Pippi-Salle urethral lengthening procedure; experience and outcome from three United Kingdom centres. BJU Int 1999; 84: 701–5 69 McGuire EJ, Wang CC, Usitalo H, Savastano J. Modified pubovaginal sling in girls with myelodysplasia. J Urol 1986; 135: 94 70 Peters CA, Bauer SB, Colodny AH et al. The use of rectus fascia to manage urinary incontinence. J Urol 1989; 142: 516 71 Elder JS. Periurethral and pubovaginal sling repair for incontinence in patients with myelodysplasia. J Urol 1990; 144: 434 72 Nguyen HT, Bauer SB, Diamond DA, Retik AB. Rectus fascial sling for the treatment of neurogenic sphincteric incontinence in boys: is it safe and effective? J Urol 2000; 166: 658–61 73 Perez LM, Smith EA, Broecker BH, Massad CA, Parrott TS, Woodard JR. Outcome of sling cystourethropexy in the pediatric population: a critical review. J Urol 1996; 156: 642–6 74 Mitrofanoff P. Cystometric continente trans-appendiculaire dans le traitement de vessies neurologiques. Chir Pediatr 1980; 21: 297 75 Duckett JW, Snyder HM III. Continent urinary diversion. variations of the Mitrofanoff principle. J Urol 1986; 136: 58 76 Kaefer M, Tobin M, Hendren WH et al. Continent urinary diversion: the Children's Hospital experience. J Urol 1997; 157: 1394–9 77 Griffiths DM, Malone PS. The Malone antegrade continence enema. J Pediatr Surg 1995; 30: 68–71 78 Roberts JP, Moon S, Malone PS. Treatment of neuropathic urinary and fecal incontinence with synchronous bladder reconstruction and the antegrade continence enema procedure. Br J Urol 1995; 75: 386–9 79 Hendren WH. Urinary tract re-functionalization after long-term diversion. A 20 year experience with 177 patients. Ann Surg 1990; 212: 478–94 80 Perlmutter AD. Experiences with urinary undiversion in children with neurogenic bladder. J Urol 1980; 123: 402–6 81 Bauer SB, Colodny AH, Hallet M, Khoshbin S, Retik AB. Urinary undiversion in myelodysplasia. criteria for selection and predictive value of urodynamic evaluation. J Urol 1980; 124: 89–93 82 Frank JD, Karthaus HF, Johnston SR, Ransley PG. An approach to undiversion in children. Br J Urol 1982; 54: 700–2 83 Casale AJ, Colodny AH, Bauer SB, Retik AB. The use bowel interposed between proximal and distal ureter in urinary tract reconstruction. J Urol 1985; 134: 737– 40 84 Mitchell ME, Rink RC. Urinary diversion and undiversion. Urol Clin North Am 1985; 12: 111–22 85 Shalhub IT, Barnes WF. Urinary undiversion in myelodysplasia. Mil Med 1988; 153: 356–7 86 Tarcan T, Bauer S, Olmedo E et al. Long-term follow-up of newborns with myelodysplasia and normal urodynamic findings: is it necessary? J Urol 2001; 165: 564–7 87 Spindel MR, Bauer SB, Dyro FM et al. The changing neuro-urologic lesion in myelodysplasia. JAMA 1987; 258: 1630 88 Epstein F. Meningocele: pitfalls in early and late management. Clin Neurosurg 1982; 30: 366 89 Reigel DH. Tethered spinal cord. Concepts Pediatr Neurosurg 1983; 4: 142 90 Venes JL, Stevens SA. Surgical pathology in tethered cord secondary to meningomyelocele repair. Concepts Pediatr Neurosurg 1983; 4: 165 91 Begger JH, Meihuizen de Regt MJ, Hogen Esch I et al. Progressive neurologic deficit in children with spina bifida aperta. Z Kinderchir 1986; 41 (Suppl. 1): 13 92 Oi S, Yamada H, Matsumoto S. Tethered cord syndrome versus low-placed conus medullaris in an over-distended cord following initial repair for myelodysplasia. Childs Nerv Syst 1990; 6: 264 93 Lais A, Kasabian NG, Dyro FM, Scott RM, Kelly MD, Bauer SB. Neurosurgical implications of continuous neuro-urological surveillance of children with myelodysplasia. J Urol 1993; 150: 1879 94 Dator DP, Hatchett L, Dyro FM, Shefner JM, Bauer SB. Urodynamic dysfunction in walking myelodysplastic children. J Urol 1992; 148: 362 95 Pontari MA, Keating M, Kelly M, Dyro F, Bauer SB. Retained sacral function in children with high level myelodysplasia. J Urol 1995; 154: 775 96 Bruner JP, Tulipan N, Paschall RL et al. Fetal surgery for Myelomeningocele and the incidence of shunt dependent hydrocephalus. JAMA 1999; 282: 1819–25 97 Holzbeierlein J, Pope JC, Adams MC et al. The urodynamic profile of myelodysplasia in childhood with spinal canal closure during gestation. J Urol 2000; 164: 1336 98 Mazzola CA, Albright AL, Sutton LN, Tuite GF, Hamilton RL, Pollack IF. Dermoid inclusion cysts and early spinal cord tethering after fetal surgery for myelomeningocele. New Engl J Med 2002; 347: 256–9 99 Palomaki GE, Williams JR, Haddow WE. Prenatal screening for open neural-tube defects in Maine. New Engl J Med 1999; 340: 1049–50 100 Czeizel AE, Dudas I. Prevention of the first occurrence of neural-tube defects by preconceptual vitamin supplementation. New Engl J Med 1992; 321: 1832–5 101 Centers for Disease Control MMWR. Recommendations for the Use of Folic Acid to Reduce the Number of Cases of Spina Bifida and Other Neural Tube Defects. US Department of Health & Human services. September 11, 1992: 41: 1–7 102 MRC Vitamin Study Research Group. Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. Lancet 1991; 338: 131 103 Stein SC, Feldman JG, Friedlander M et al. Is myelomeningocele a disappearing disease? Pediatrics 1982; 69: 511 104 Copp AJ. Neural tube defects. Trends Neurosci 1993; 16: 381–3 Citing Literature Volume92, Issues1October 2003Pages 23-28 ReferencesRelatedInformation
Referência(s)